SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 81 filers reported holding SERES THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $64,000 | -81.0% | 19,820 | -56.9% | 0.00% | -71.4% |
| Q1 2018 | $337,000 | +74.6% | 45,952 | +141.3% | 0.01% | +55.6% |
| Q4 2017 | $193,000 | -52.8% | 19,043 | -25.4% | 0.01% | -57.1% |
| Q3 2017 | $409,000 | +209.8% | 25,533 | +117.2% | 0.02% | +250.0% |
| Q1 2017 | $132,000 | – | 11,756 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |